Skip to content

Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.

Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00601185
Enrollment
116
Registered
2008-01-25
Start date
2006-02-14
Completion date
2018-02-23
Last updated
2018-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal Cell Carcinoma, Melanoma, Non-Malignant Skin Disorders, Squamous Cell Carcinoma

Keywords

06-009, Confocal reflectance microscopy, shave-biopsy

Brief summary

The purpose of this study is to evaluate a new instrument that shines light and takes digital pictures of skin. The goal is to develop a technique that may enable fast and accurate detection of skin disorders and cancers for future clinical diagnosis and surgical use.

Interventions

A dermatologist will perform a shave biopsy according to standard clinical procedures. This study will be carried out after the shave biopsy. The deep surface and the peripheral margins will be imaged on each patient.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing shave-biopsy on an anatomical site that is readily accessible to the VivaScope 1500 (for example, chest, back, legs, arms, cheek, forehead). * The additional 110 patients for this amendment will be imaged with the newly developed Vivascope 3000 handheld confocal microscope. * Ability to sign informed consent. * Age ≥ 18 years.

Exclusion criteria

* Shave-biopsy located on a site that is not amenable to confocal imaging (for example, adjacent to the nose, ears or eyes, fingers, toes). * Inability to give informed consent. * Known hypersensitivity to adhesive rings. * Inability to tolerate imaging procedure (i. e., remain relatively still for multiple short durations of 3-4 minutes).

Design outcomes

Primary

MeasureTime frame
is to evaluate and quantify the technical feasibility of reflectance CSLM imaging of shave-biopsy sites on skin in vivo.conclusion of study

Secondary

MeasureTime frame
To assess the quality of the CSLM images of the biopsy sites to determine a point estimate of the proportion of images that will be of acceptable quality for formal analysis in the planned study of intraoperative margin detection.conclusion of study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026